Prostate development discovery could lead to new treatments
2/07/2014
Scientists at the University of York have discovered how the prostate gland develops for the first time, according to research published in Cell Press.
A recent paper published in European Urology, the official journal of the European Association of Urology, indicates that the gonadotropin releasing hormone (GnRH) antagonist degarelix (brand name: FIRMAGON®), may halve the relative risk of cardiovascular (CV) events and death in men with pre-existing CV disease (CVD) compared to treatment with commonly prescribed luteinising...
Immune treatment for MS shows promise
2/07/2014
A new treatment that boosts immunity to Epstein-Barr virus may benefit patients with multiple sclerosis, according to the results of an Australian study published in the Multiple Sclerosis Journal.
Prostate development discovery could lead to new treatments
2/07/2014
Scientists at the University of York have discovered how the prostate gland develops for the first time, according to research published in Cell Press.
A recent paper published in European Urology, the official journal of the European Association of Urology, indicates that the gonadotropin releasing hormone (GnRH) antagonist degarelix (brand name: FIRMAGON®), may halve the relative risk of cardiovascular (CV) events and death in men with pre-existing CV disease (CVD) compared to treatment with commonly prescribed luteinising...
Immune treatment for MS shows promise
2/07/2014
A new treatment that boosts immunity to Epstein-Barr virus may benefit patients with multiple sclerosis, according to the results of an Australian study published in the Multiple Sclerosis Journal.
Public divided on genetic testing to predict cancer risk
2/07/2014
A national poll from the University of Utah's Huntsman Cancer Institute shows 34 percent of respondents would not seek genetic testing to predict their likelihood of developing a hereditary cancer - even if the cost of the testing was not an issue.Concerns about employment and insurability were cited as the primary reason, even though current laws prohibit such discrimination.
3D mapping biopsy found pockets of prostate cancer previous technique had missed
2/07/2014
Ultrasound-guided biopsies miss prostate cancers that are detected by the slightly more expensive and slightly more invasive 3D mapping biopsies.
Unprecedented images of hydrated protein molecules made possible using graphene balloon
2/07/2014
A graphene water balloon may soon open up new vistas for scientists seeking to understand health and disease at the most fundamental level.Electron microscopes already provide amazingly clear images of samples just a few nanometers across. But if you want a good look at living tissue, look again.
Male obesity could dictate future colon screenings
2/07/2014
Obesity is a known risk factor for many cancers including colon cancer, yet the reasons behind the colon cancer link have often remained unclear.